DAY 1: 01 September

0830: Registration

0930-1800: Presentations including lunch and refreshments

1915: Networking dinner (please check your email for further details)

DAY 2: 02 September

0900: Accommodation checkout

0930-1530: Presentations including lunch and refreshments

1550: Close of conference

Confirmed Speakers

Professor Martha Clokie (conference chair)
Department of Genetics & Genome Biology & Becky Mayer Centre for Phage Research, University of Leicester, Leicester, UK
UTI phages; ecological insights, antibiotic synergies, and bladder models

Professor Rob Lavigne
Faculty of Bioscience Engineering & Head, Animal and Human Health Engineering, Laboratory of Gene Technology, University of Leuven, Leuven, Belgium
TBA

Dr Mikeljon Nikolich
Bacteriophage Therapeutics, Wound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA
Durable Fixed Cocktails Incorporating Globally Harvested Bacteriophages as Novel Antimicrobials for Multidrug-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae Infections

Professor Krystyna Dabrowska
Wrocław University of Science and Technology, Medical Faculty, Wrocław, and Hirszfeld Institute of Immunology and Experimental Therapy, Wrocław, Poland
Specific immune responses to phage therapy: the gut context

Professor Amaya Albalat
Institute of Aquaculture, University of Stirling, Stirling, UK
TBA

Professor Thomas Sicheritz-Pontén
Center for Evolutionary Hologenomics, The Globe Institute, University of Copenhagen, Denmark

Dr Marie-Agnès Petit
Université Paris-Saclay, AgroParisTech, INRAE, MICALIS, Jouy en Josas, France
Complementary killing activities of Pbunavirus LS1 and Bruynoghevirus LUZ24 phages on planktonic and sessile Pseudomonas aeruginosa PAO1 derivatives

Dr Carola Venturini
Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, Australia
Development of phage-based interventions against UPEC for companion animals with recurrent UTI

Professor Sebastian Leptihn
Department of Biochemistry, Health and Medical University Erfurt, Germany
A Genetic “Bulls-Eye”: Dissecting Fitness in Evolving Phage Populations

Professor Stefan Vermeulen
Research Center Health & Water Technology (HWT), University College Ghent, Keramiekstraat, Gent, Belgium
Development of a microfluidic platform for accurate and universal quantification of phages

Professor Belinda Loh
Fraunhofer Institute for Cell Therapy & Immunology (IZI), Department of Infection Research & Diagnostics, Leipzig, Germany
Strategic Receptor Profiling Optimizes Phage Therapy for K1 Klebsiella pneumoniae

Dr Florian Sigloch
PolyQuant GmbH, Industriestr 1, Bad Abbach, Germany
Universal host contaminant protein identification and quantification for any production host by LC-MS/MS

Dr Nina Vesel
Department of Microbiology, Biotechnical faculty, University of Ljubljana, Ljubljana, Slovenia
Deciphering bacterial host control by phage regulatory switches at single cell level

Dr Gábor Apjok
Biological Research Centre, Institute of Biochemistry, Szeged, Hungary
Dissecting the Human Gut Phageome Reveals Genetic Drivers of Epithelial Interactions and Intracellular Trafficking

Miss Kiran Bosco
Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia
Mammalian immune responses to phage therapy: Insights from clinical and experimental studies

Mr Adrian Thaqi
Emmy Noether Research Group “Virus in Nature and Health” (Deng Lab), Institute of Virology (HMGU), Technical University of Munich (TUM), Neuherberg, Germany
Prophages Reshape Metabolism, Stress Tolerance, Biofilm Formation and Phage Resistance in Enterotoxigenic Escherichia coli

Mr Ruizhe Li
Department of Engineering, University of Cambridge, Trumpington Street, Cambridge, UK
Host cell cycle and ribosomal resources drive T7 phage infection outcomes

Miss Sónia Campos
Institute of Virology, Helmholtz Munich, Neuherberg, Germany
The Relevance of Phage-Encoded Proteins Against Chronic Acinetobacter baumannii Biofilm Infections in Mucosal Environments

Dr Tingjie Guo
Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands
Reframing PK/PD for rational treatment strategies in phage therapy

Dr Hannah Bonham
Department of Microbiology, Biotechnical faculty, University of Ljubljana, Ljubljana, Slovenia
Capturing Infection in Action: Developing a Fluorescence Imaging Pipeline to Study Bacteriophage Infection and Lysis

Dr Ryan Cochrane
Department of Chemistry, Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, UK
Smart-Phage: Towards Bottom-up Genome Engineering Technologies for PB1-like Bacteriophage

Dr Mojgan Rabiey
NIAB EMR, New Road, East Malling, UK
Impact of phage therapy on Pseudomonas syringae pv. syringae and plant microbiome dynamicsthrough coevolution and field experiments

Mr Hubert Kasprzak
Bacteriophage Laboratory, Phage Therapy Department, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland
Studies on the effects of bacteriophages on cytokine production by human peripheral blood immune cells   

Mr Shahzeb Javed
Drug Discovery and Development, University of Salerno (SA), Italy
Stabilizing Bacteriophages in Alginate Hydrogels for 3D Printing Applications: a Customizable Platform for Targeted Antibacterial Therapy

Miss Aparna Kaaraal Mohan
Department of Engineering, University of Cambridge, Trumpington Street, Cambridge, UK
Single-cell analysis of the effects of cellular dormancy on the efficacy of bacteriophages

Mr Gabriel Abreu
CEB-Centre of Biological Engineering, University of Minho, Braga, Portugal
From Genotype to Phenotype: Linking Erwinia amylovora Diversity to Bacteriophage Host Range

Miss Arezoo Pedramfar
Becky Mayer Centre for Phage Research, Department of Genetics, Genomics and Cancer Sciences (GGCS), University of Leicester, Leicester, UK
The development of targeted phage metagenomics

Mr Andrew Kinsella
Becky Mayer Centre for Phage Research, Department of Genetics, Genomics and Cancer Sciences (GGCS), University of Leicester, Leicester, UK
Investigating the prevalence and diversity of prophages in Enterococcus genomes, and their role in AMR and virulence spread